US Endoscopy Capsules Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)
US Endoscopy Capsules Market: by Type (Small Bowel, Colon, Esophageal, Others), Application (Obscure GI Bleeding, Crohnâs Disease, Small Intestine Tumor, Celiac Disease, Inherited Polyposis Syndromes, Others), Distribution Channels (Hospitals, Ambulatory Surgery Centers, Diagnostic Laboratories, Clinics, Others), Technology (Wireless, Wired, Robotic Assisted, Imaging Technology, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Last Updated: 31-07-2025 | Format: PDF | Report ID:20146 | Author: Lily
US Endoscopy Capsules Market Outlook & Forecast 2025-2035
The US endoscopy capsules market refers to the segment of medical devices used for minimally invasive diagnostic procedures of the gastrointestinal (GI) tract using ingestible capsule cameras. These capsules capture images and transmit them wirelessly, providing clinicians with detailed views of the small bowel, colon, esophagus, and other GI tract regions without the need for traditional endoscopy. The market is defined by technological innovations, increasing prevalence of GI disorders, patient preference for non-invasive diagnostics, and the expansion of applications such as Crohn’s disease, obscure GI bleeding, and small intestine tumors. The market encompasses various device types, applications, technologies, and distribution channels, reflecting a comprehensive value chain involving hospitals, clinics, ambulatory surgical centers, and diagnostic laboratories. Key players continually invest in imaging advancements, wireless transmission, and improved battery life to gain a competitive edge, while regulatory frameworks and reimbursement scenarios significantly influence market dynamics.
Latest Market Dynamics
Key Drivers
Rise in gastrointestinal disorders: Increasing prevalence of digestive diseases, particularly Crohn's disease and colorectal cancer, is propelling demand for endoscopy capsules. Medtronic’s PillCam platform continues to see strong adoption in 2025 due to expanded indications and improved accessibility.
Patient preference toward less invasive diagnostics: Surge in demand for non-invasive screening techniques is fueling widespread uptake. Olympus Corporation reported increased US product utilization following recent FDA nods and patient-centric marketing in 2025.
Key Trends
Integration of AI in diagnostic imaging: Market players are deploying artificial intelligence to enhance image analysis accuracy and efficiency, facilitating quicker and more precise GI screenings. CapsoVision launched an AI-enabled platform in early 2025 for faster diagnostic workflows.
Miniaturization and multi-functional capsules: Continuous development of smaller capsules capable of high-resolution imaging and extended battery life. IntroMedic’s latest 2025 release delivered a more compact design with dual imaging capabilities, addressing current clinical demands.
Key Opportunities
Expanded clinical indications: Broader FDA approvals for capsule endoscopy in pediatric and high-risk elderly populations open new revenue streams. Boston Scientific announced plans in Q2 2025 to extend clinical validation studies to capture these segments.
Growth in ambulatory settings: Increasing adoption within ambulatory surgical centers and diagnostic labs due to operational cost savings and workflow efficiency. Check-Cap secured strategic partnerships with multiple ambulatory centers in 2025.
Key Challenges
High device and procedure cost: Despite technical advancements, high initial investments hinder adoption in certain facilities. Stryker highlighted pricing barriers as a top concern in its Q1 2025 US endoscopy division update.
Limited reimbursement coverage: Gaps in national reimbursement and insurance policy acceptance restrict broader deployment, particularly among smaller providers. RF System Lab flagged slow progress in reimbursement policy harmonization in its 2025 earnings report.
Key Restraints
Technical limitations in battery life and data transmission: Some capsules still face challenges in processing long GI tract journeys and uninterrupted data transfer. Olympus addressed ongoing R&D to mitigate such technical restraints in its April 2025 R&D roadmap.
Risk of capsule retention and incomplete transit: Clinical risk associated with retention, especially in strictured or narrowed intestinal passages, remains a limiting factor noted by Carl Zeiss Meditec AG in their safety advisory June 2025.
The US endoscopy capsules market by type demonstrates significant dominance in small bowel capsule endoscopes, accounting for the majority share due to their established clinical use and wider acceptance. Colon capsules have gained noteworthy traction, attributed to their evolving technology and expanded approvals for colorectal cancer screening. Esophageal and stomach capsules represent growing segments, targeting specific niches such as Barrett’s esophagus and pediatric diagnostics. Pediatric and other specialized capsule types remain a smaller but promising segment, propelled by clinical innovation and tailored device development. The market's segmentation by type is shaped by ongoing advancements in miniaturization, improved battery life, and FDA approvals expanding capsules' indications beyond traditional small bowel endoscopy.
In 2025, obscure GI bleeding remains the leading application for endoscopy capsules in the US, owing to the challenges of diagnosing the precise source of bleeding within the small intestine using conventional techniques. Crohn’s disease is the second-largest segment, supported by the increasing prevalence and high diagnostic value of capsule technology in assessing disease extent. Applications such as small intestine tumor detection and inherited polyposis syndromes are witnessing increased adoption due to their minimally invasive nature and comprehensive imaging capabilities. Others, including celiac disease monitoring, add to the expanding versatility of capsule endoscopy technology. This distribution reflects a dynamic shift towards personalized, indication-driven capsule deployments in both hospital and ambulatory care settings.
The US endoscopy capsules market revenue is projected to grow robustly, with total revenues reaching 455 million USD in 2025 and showing sustained CAGR through 2035. This trajectory reflects increased diagnostic demand, clinical adoption in ambulatory settings, and ongoing product innovation by key market players. The chart underscores a consistent upward momentum, driven by both increased incidence of GI conditions and expanded insurance coverage for non-invasive diagnostics. Gradual entry of new competing technologies and providers is expected to diversify the revenue base further by 2030.
US Endoscopy Capsules Market Year-on-Year Growth (2020-2035)
The year-on-year (YOY) growth in the US endoscopy capsules market reflects resilient momentum, with an average YOY rate of 8-10% through the initial part of the forecast period. This pace is sustained by successive product launches, favorable regulatory shifts, and rising clinical preference for non-invasive diagnostics across broader patient populations. YOY growth rates are projected to slightly taper in later years as the market matures and approaches saturation, but continued innovation and expansion into untapped clinical segments are likely to maintain positive growth through 2035.
The US endoscopy capsules market in 2025 is primarily concentrated in the Northeast and West regions, which account for the largest overall market share due to high patient volumes, extensive hospital networks, and robust reimbursement environments. The Midwest region demonstrates notable growth owing to ongoing investment in ambulatory surgical infrastructure and adoption in smaller urban centers. The South, though representing a smaller share currently, is poised for future expansion as healthcare infrastructure and specialty diagnostics grow. This diverse regional distribution points to varying adoption rates shaped by demographic, economic, and healthcare policy factors.
Medtronic leads the US endoscopy capsules market in 2025, capturing a significant portion due to its comprehensive PillCam product line and broad distribution network. Olympus Corporation and IntroMedic trail with competitive shares, driven by their innovative approaches to imaging and connectivity. Additional notable players such as CapsoVision and Boston Scientific hold meaningful positions, underpinned by ongoing investments in R&D and portfolio differentiation. The market’s structure highlights a concentration among top players, yet leaves room for emerging entrants with disruptive technology and targeted clinical solutions.
Hospitals represent the primary buyer group for endoscopy capsules in the US, due to their central role in complex GI diagnostics and access to reimbursement. Ambulatory surgery centers are rapidly increasing their share, propelled by procedural efficiency and cost-effectiveness. Diagnostic laboratories and clinics make up the remainder, illustrating a multi-channel approach to broadening market reach. The distribution reflects the shift towards decentralized diagnostics, supporting faster patient turnover and improved access to non-invasive screening procedures.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
455
Regions
Northeast, West, Midwest, South
Segments
Small Bowel, Colon, Esophageal, Stomach, Pediatric, Others; Obscure GI Bleeding, Crohn’s Disease, Small Intestine Tumor, Celiac Disease, Inherited Polyposis Syndromes, Others
June 2024: CapsoVision launches CapsoCam® AI platform, enhancing automated image interpretation and workflow efficiency.
July 2024: Olympus Corporation receives expanded FDA approval for its new colon capsule endoscope for colorectal screening in the US.
August 2024: Check-Cap announces partnership with Premier Ambulatory Centers to expand capsule access in outpatient care settings.
September 2024: Medtronic introduces enhanced battery life and dual imaging PillCam® for pediatric and small intestine diagnostics.
October 2024: Boston Scientific initiates multi-center clinical trials on capsule endoscopy for new clinical indications, including pediatric applications.
Frequently Asked Questions
About the Author
Lily
Senior Market Research Analyst
Lily is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Medical Devices. Lily brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Lily has helped organizations translate data into actionable growth strategies.
Medical DevicesMarket ResearchIndustry AnalysisStrategic Consulting
Key Questions Answered
»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?
